Abbott launches heart/kidney risk tool
Abbott launched the ICRAS tool to identify early heart and kidney risks related to diabetes.
The tool, called the Integrated Cardio-Renal Assessment System (ICRAS), is designed to help doctors identify high-risk patients. It uses AI to analyze patient data and predict the likelihood of developing heart and kidney complications. ICRAS analyzes routine blood test results to generate a risk score. This score helps doctors determine which patients need more aggressive treatment. This launch comes as diabetes-related heart and kidney diseases are on the rise. Early identification and intervention are crucial to improving patient outcomes.
